GIORGI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 28.102
AS - Asia 14.722
EU - Europa 11.608
SA - Sud America 2.973
OC - Oceania 490
AF - Africa 418
Continente sconosciuto - Info sul continente non disponibili 17
Totale 58.330
Nazione #
US - Stati Uniti d'America 26.817
SG - Singapore 4.110
CN - Cina 3.751
IT - Italia 3.123
HK - Hong Kong 2.772
BR - Brasile 2.187
GB - Regno Unito 1.331
VN - Vietnam 1.204
PL - Polonia 1.035
SE - Svezia 995
BG - Bulgaria 935
CA - Canada 916
DE - Germania 738
TR - Turchia 657
FR - Francia 576
RU - Federazione Russa 547
IN - India 498
FI - Finlandia 484
UA - Ucraina 422
AU - Australia 411
JP - Giappone 346
KR - Corea 331
CL - Cile 267
MX - Messico 243
CH - Svizzera 238
NL - Olanda 231
ES - Italia 207
AR - Argentina 163
BD - Bangladesh 157
ID - Indonesia 153
CO - Colombia 112
AT - Austria 98
PT - Portogallo 98
IE - Irlanda 97
IQ - Iraq 92
IR - Iran 91
ZA - Sudafrica 88
EG - Egitto 84
EC - Ecuador 83
BE - Belgio 82
GR - Grecia 82
NZ - Nuova Zelanda 79
PK - Pakistan 78
TH - Thailandia 77
TW - Taiwan 65
PE - Perù 55
VE - Venezuela 53
CI - Costa d'Avorio 45
RO - Romania 43
SA - Arabia Saudita 43
CZ - Repubblica Ceca 36
PH - Filippine 36
UZ - Uzbekistan 36
HU - Ungheria 35
JO - Giordania 35
MA - Marocco 35
MY - Malesia 35
DK - Danimarca 34
SN - Senegal 33
CR - Costa Rica 28
DZ - Algeria 26
NP - Nepal 25
LV - Lettonia 24
IL - Israele 23
KE - Kenya 21
TN - Tunisia 20
UY - Uruguay 19
NG - Nigeria 18
NO - Norvegia 18
PY - Paraguay 18
JM - Giamaica 17
AE - Emirati Arabi Uniti 15
KZ - Kazakistan 15
ET - Etiopia 14
PA - Panama 14
BO - Bolivia 13
KH - Cambogia 13
LT - Lituania 13
EU - Europa 12
GT - Guatemala 11
SK - Slovacchia (Repubblica Slovacca) 11
AZ - Azerbaigian 10
BJ - Benin 10
RS - Serbia 10
BY - Bielorussia 9
OM - Oman 9
TT - Trinidad e Tobago 9
EE - Estonia 8
MK - Macedonia 8
AL - Albania 7
BB - Barbados 7
DO - Repubblica Dominicana 7
HR - Croazia 7
MT - Malta 7
BN - Brunei Darussalam 6
HN - Honduras 6
KG - Kirghizistan 6
LY - Libia 6
PS - Palestinian Territory 6
BH - Bahrain 5
Totale 58.236
Città #
Woodbridge 3.021
Hong Kong 2.733
Ashburn 2.380
Singapore 2.273
Ann Arbor 1.963
Houston 1.813
Fairfield 1.736
Chandler 1.356
San Jose 1.299
Santa Clara 1.017
Milan 966
Dallas 963
Sofia 932
Beijing 853
Seattle 738
Shanghai 731
Wilmington 702
New York 670
Cambridge 621
Jacksonville 596
Ottawa 585
Serra 468
Princeton 467
Boardman 427
Lawrence 379
Izmir 356
Medford 340
Lauterbourg 337
Nanjing 334
Hefei 327
Los Angeles 285
Council Bluffs 281
Ho Chi Minh City 270
Tokyo 269
Redwood City 264
Seoul 252
Des Moines 206
Bern 182
Hanoi 182
Istanbul 174
São Paulo 173
Rome 156
Buffalo 145
Dearborn 141
Redondo Beach 141
Santiago 137
Dong Ket 134
Nanchang 120
Menlo Park 114
Helsinki 111
London 109
San Diego 109
Jüchen 108
Sydney 98
Munich 90
Columbus 86
Boulder 82
Frankfurt am Main 82
Shenyang 82
Falls Church 81
Montréal 71
The Dalles 71
Manchester 70
Vienna 70
Melbourne 67
Rio de Janeiro 66
Kunming 65
Hebei 64
Bogotá 61
Guangzhou 61
Ogden 59
Khulna 58
Changsha 57
Ames 55
Mumbai 55
Orem 53
Pune 53
Tianjin 53
Curitiba 52
Pisa 48
Belo Horizonte 46
Brisbane 46
Cairo 46
Amsterdam 45
Chennai 45
Abidjan 44
Norwalk 44
Jakarta 43
Jiaxing 43
San Francisco 43
Chicago 42
Montreal 42
Fuzhou 41
Hangzhou 41
Mcallen 40
Utrecht 40
Birmingham 39
Bristol 39
Florence 39
Atlanta 38
Totale 38.102
Nome #
Trazodone: A review of its pharmacological properties and its off-label use in dogs and cats 3.837
Paracetamol: A Focus on Dogs 1.588
DEVELOPMENT AND VALIDATION OF A NEW HPLC-FLUORIMETRIC METHOD TO DETERMINE EPIRUBICIN AND ITS METABOLITEEPIRUBICINOL IN DOG PLASMA 1.033
ANTINOCICEPTIVE PROPERTIES OF HYDRO ALCOHOLIC EXTRACTS OF ANETHUM GRAVEOLENS L. (DILL) SEED AND AERIAL PARTS IN MICE 450
BIOPHARMACEUTICS OF METOCLOPRAMIDE: INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS AND PER RECTUM ADMINISTRATIONS IN RABBITS 436
CJ-023,423 (Grapiprant) a potential novel active compound with antihyperalgetic properties for veterinary patients 343
A BRIEF OVERVIEW OF THE COXIB DRUGS IN THE VETERINARY FIELD 317
Pilot in vivo investigation of cerium oxide nanoparticles as a novel anti-obesity pharmaceutical formulation 289
MIRTAZAPINE IN BEAGLE DOGS 284
Novel LC-MS/MS method for CJ-023423 (Grapiprant) determination in rabbit plasma 271
Pharmacokinetics of Bedrocan (marijuana extract oil) in fasted and fed dogs: a pilot study 269
EVALUATION OF PLASMA DETECTABLE CONCENTRATIONS OF TWO LIDOCAINE TRANSDERMAL FORMULATIONS AND THEIR ANALGESIC EFFECT IN THE HORSE 246
Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment 246
First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study 243
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 242
Analytical Method Validation of Vilazodone with Spectrofluorimetric Detection in Rabbit Plasma 238
Anticonvulsant activity of hydroalcoholic phoenix dactylifera fruit extract and pimpinella anisum oil in mice 227
A NEW HPLC METHOD FOR THALIDOMIDE DETECTION IN HUMAN PLASMA 224
Pharmacokinetic and pharmacodynamic evaluations of levofloxacin in broiler chickens 219
Natural substances as new potential strategies for the treatment of Leishmaniosisin Dogs 219
USE OF A LASERCYTE® FOR THE COMPLETE BLOOD COUNT IN DOGS WITH ONCOHEMATOLOGICAL DISORDERS 216
PHARMACOKINETIC/PHARMACODYNAMIC ASSESSMENTS OF 10 MG/KG TRAMADOL INTRAMUSCULAR INJECTION IN YELLOW-BELLIED SLIDER TURTLES (TRACHEMYS SCRIPTA SCRIPTA). 216
Bioanalytical Method Validation and Quantification of Flupirtine in Canine Plasma by HPLC with Spectrofluorimetric Detection 216
DEVELOPMENT AND VALIDATION OF A NEW GC-MS METHOD FOR DETECTION OF TRAMADOL, O-DESMETHYLTRAMADOL, 6-ACETYLMORPHINE AND MORPHINE IN BLOOD, BRAIN, LIVER, AND KIDNEY OF WISTAR RATS TREATED WITH THE COMBINATION OF HEROIN AND TRAMADOL 207
DEVELOPMENT AND VALIDATION OF A NEW GC-MS METHOD FOR DETECTION OF TRAMADOL, O-DESMETHYLTRAMADOL, 6-ACETYLMORPHINE AND MORPHINE IN BLOOD, BRAIN, LIVER, AND KIDNEY OF WISTAR RATS TREATED WITH THE COMBINATION OF HEROIN AND TRAMADOL 203
INULIN BASED HYDROGEL FOR ORAL DELIVERY OF FLUTAMIDE: PREPARATION, CHARACTERIZATION AND IN VIVO RELEASE STUDIES 199
PILOT IN VIVO TOXICOLOGICAL INVESTIGATION OF BORON NITRIDE NANOTUBES 197
NEW HPLC METHOD TO DETECT INDIVIDUAL OPIOIDS (HEROIN AND TRAMADOL) AND THEIR METABOLITES IN THE BLOOD OF RATS ON COMBINATION TREATMENT 194
Gabapentin in Cattle: A Pharmacology Snapshot 191
Pharmacokinetics of Sulpiride Following Intravenous, Intramuscular and Oral Single Dose Administration in Nurse Mares 190
Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4′-hydroxy praziquantel in beagle dogs 186
COMPARISON OF INJECTABLE PARECOXIB VERSUS ROBENACOXIB FOR PERI-OPERATIVE USE IN DOGS: PRELIMINARY RESULTS 186
Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit 185
Pharmacokinetics of Metoclopramide After IntraARTERIAL, Intramuscular, Subcutaneous, and Perrectal Administration in Rabbits 184
Pharmacokinetics of Bedrocan®, a cannabis oil extract, in fasting and fed dogs: An explorative study 184
PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLPIDEM AFTER ORAL ADMINISTRATION OF A SINGLE DOSE IN DOGS 183
Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes 183
PHARMACOKINETICS OF METHYLPHENIDATE AFTER ORAL ADMINISTRATION OF IMMEDIATE AND SUSTAINED RELEASE PREPARATIONS IN BEAGLE DOGS 181
BIOCOMPATIBILITY OF BORON NITRIDE NANOTUBES: AN UP-DATE OF IN VIVO TOXICOLOGICAL INVESTIGATION 181
Validation of an HPLC-FL method for the determination of tepoxalin and its major metabolite in horse plasma 180
ABNORMAL FINDINGS IN HAEMOGRAMS OF DACHSHUND PUPPIES: PRESUMPTIVE (IMMUNODEFICIENCY) FAMILIAL DISEASE 179
PHARMACOKINETIC INVESTIGATIONS OF THE MARKER ACTIVE METABOLITE-4-METHYLAMINO-ANTIPYRIN AFTER INTRAVENOUS AND INTRAMUSCULAR INJECTION OF METAMIZOLE IN HEALTHY SHEEP 179
hCG is more effective than the GnRH agonist buserelin for inducing the first ovulation of the breeding season in mares 179
A BRIEF OVERVIEW OF OUR CURRENT UNDERSTANDING OF NIVALENOL: A GROWING POTENTIAL DANGER YET TO BE FULLY INVESTIGATED 177
Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers 177
CLINICAL INTERACTION BETWEEN GRAPEFRUIT-JUICE AND CYCLOSPORINE: IS THERE ANY INTEREST FOR VETERINARY MEDICINE? 176
PHARMACOKINETICS OF METHYLPHENIDATE FOLLOWING TWO ORAL FORMULATIONS (IMMEDIATE AND SUSTAINED RELEASE) IN THE DOG 176
A comparative kinetic study of thiamphenicol in pre-ruminant lambs and calves 176
Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology. 176
QUANTIFICATION OF TAPENTADOL IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION: DEVELOPMENT AND VALIDATION OF A NEW METHODOLOGY 176
Pharmacokinetics of levosulpiride after single-dose administration by different routes in sheep (Ovis aries Linnaeus) 176
GLI ANALGESICI IN MEDICINA VETERINARIA. Animali da compagnia (oppioidi, a2 agonisti e ketamina) 175
PHARMACOKINETIC PROFILES OF THE NOVEL COX-2 SELECTIVE INHIBITOR CIMICOXIB IN DOGS 174
Pharmacokinetics of meloxicam in lactating goats (Capra hircus) and its quantification in milk after a single intravenous and intramuscular injection 174
Analgesici oppiodi: HPLC-FL e LC-UV-ESI-MS/MS per la determinazione simultanea del tramadolo e dei suoi metaboliti nel plasma di cavallo 173
Pharmacokinetics and disposition of flupirtine in the horse 173
PHARMACOKINETCIS STUDY OF CLAZURIL (APPERTEX®) IN EGGS AND PLASMA FROM LAYING HENS AFTER SINGLE AND MULTIPLE TREATMENT BY A NEW HPLC METHOD 172
PHARMACOKINETIC OF TRAMADOL AND ITS MAJOR CONJUGATES AFTER SINGLE PER OS ADMINISTRATION OF THE SUSTAINED TABLET AND PER RECTUM SUPPOSITORIES FORMULATIONS IN DOGS 172
ANIMAL POISONING FREQUENCY IN CENTRAL ITALY (YEARS 2003-2004) 171
EVALUATION OF TRAMADOL AND ITS MAIN METABOLITES IN HORSES PLASMA BY HPLC-FL AND LC-ESI-MS/MS TECHNIQUES 171
CLINICAL AND HEMATOLOGICAL ADVERSE EFFECTS AFTER ADMINISTRATION OF TWO DIFFERENT CHEMOTHERAPY PROTOCOLS IN DOGS AFFECTED BY LYMPHOMA 170
Pharmacokinetic and pharmacodynamic evaluations of a 10 mg/kg enrofloxacin intramuscular administration in bearded dragons (Pogona vitticeps): A preliminary assessment 170
Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs 169
Role of Natural Products in Ameliorating Drugs and Chemicals Toxicity 168
BIOGENIC AMINE CONTENT IN “PECORINO DEL PARCO DI MIGLIARINO - SAN ROSSORE” 167
ORAL ADMINISTRATION OF TEPOXALIN IN THE HORSE: A PK/PD STUDY 167
Pharmacokinetics and estimated bioavailability of grapiprant, a novel selective prostaglandin E2 receptor antagonist, after oral administration in fasted and fed dogs 167
Cardiovascular effects and intraoperative pharmacokinetics of tramadol in sheep undergoing spinal surgery 167
DETECTION AND QUANTIFICATION OF CIMICOXIB, A NOVEL COX-2 INHIBITOR, IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION: DEVELOPMENT AND VALIDATION OF A NEW METHODOLOGY 166
Pharmacokinetic Assessment of the Marker Active Metabolites 4-Methyl-amino-antipyrine and 4-Acetyl-amino-antipyrine After Intravenous and Intramuscular Injection of Metamizole (Dipyrone) in Healthy Donkeys 166
Cebranopadol, a novel first-in-class drug candidate: Method validation and first exploratory pharmacokinetic study in rabbits 166
A NEW HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF IOHEXOL AND p-AMINOHIPPURIC ACID IN PLASMA OF DOGS 165
LABORATORY DIAGNOSTIC EXAMINATIONS IN VETERINARY TOXICOLOGY 165
PHARMACOKINETICS OF MIRTAZAPINE AND ITS MAIN METABOLITES AFTER SINGLE INTRAVENOUS AND ORAL ADMINISTRATIONS IN RATS AT TWO DOSE RATES 165
Effect of feeding on the pharmacokinetics of vilazodone in dogs 165
MIRTAZAPINE IN VETERINARY MEDICINE A PHARMACOLOGICAL RATIONALE FOR ITS APPLICATION IN CHRONIC PAIN 164
PHARMACOKINETICS OF INTRAVENOUS AND INTRAMUSCULAR PARECOXIB IN HEALTHY BEAGLES 164
PHARMACOKINETICS OF MIRTAZAPINE AND ITS MAIN METABOLITES AFTER SINGLE ORAL ADMINISTRATION IN FASTING/FED HORSES 164
Exposure assessment of multiple mycotoxins in black and white sesame seeds consumed in Thailand 164
A new HPLC method to determine glomerular filtration rate and effective renal plasma flow in conscious dogs by single intravenous administration of iohexol and p-aminohippuric acid 163
DETECTION AND QUANTIFICATION OF THE SELECTIVE EP4 RECEPTOR ANTAGONIST CJ-023423 (GRAPIPRANT) IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION 163
BLOOD CONCENTRATION OF ENROFLOXACIN AND ITS METABOLITE CIPROFLOXACIN IN YELLOW-BELLIED SLIDER TURTLES (TRACHEMYS SCRIPTA SCRIPTA), AFTER A SINGLE INTRACOELOMIC INJECTION OF ENROFLOXACIN 162
Pharmacokinetics of levosulpiride after single-dose administration in goats (Capra hircus) by different routes of administration 162
Impact of low-dose ozone supplementation on motility parameters and bacterial growth in horse cryopreserved semen 162
IN SITU FORMING GEL LIKE DEPOT OF A POLYASPARTAMIDE-POLYLACTIDE COPOLYMER FOR ONCE A WEEK ADMINISTRATION OF SULPIRIDE 161
ASSESSMENT OF THE PHARMACOKINETIC PROFILE OF TRAMADOL AND ITS MAIN METABOLITES IN PLASMA AND URINE FORM DOGS ORALLY ADMINISTERED WITH CONTRAMAL®, WITH OR WITHOUT FREEZE-DRIED GRAPE-FRUIT JUICE 160
PHARMACOKINETICS OF THE NOVEL ATYPICAL OPIOID TAPENTADOL FOLLOWING ORAL AND INTRAVENOUS ADMINISTRATION IN DOGS 160
Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4 '-hydroxy praziquantel in beagle dogs 160
Determination of tramadol and metabolites by HPLC-FL and HPLC-MS/MS in urine of dogs 160
HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF THALIDOMIDE IN PATIENTS AFFECTED BY HEPATOCELLULAR CARCINOMA 159
CONSTRUCTION AND EVALUATION OF SPONGE SCAFFOLDS FROM HYALURONIC ACID DERIVATIVES FOR POTENTIAL CARTILAGE REGENERATION 159
PHARMACOKINETIC EVALUATION OF TRAMADOL AND ITS MAJOR METABOLITES AFTER SINGLE ORAL SUSTAINED TABLET ADMINISTRATION IN THE DOG: A PILOT STUDY 158
Apoptosis and gene expression in Jurkat human T cells and lymphoid tissues of fusarenon-X-treated mice 158
Levofloxacin in veterinary medicine: a literature review 158
THE PHARMACOKINETICS AND IN VITRO/EX VIVO CYCLOOXYGENASE SELECTIVITY OF PARECOXIB AND ITS ACTIVE METABOLITE VALDECOXIB IN CATS 157
EU PERSPECTIVES OF BIOEQUIVALENCE TEST FOR THE APPROVAL OF GENERIC VETERINARY MEDICINAL PRODUCTS. THE ROLE OF EXCIPIENTS 156
CHARACTERIZATION OF IN VIVO PLASMA METABOLITES OF TEPOXALIN IN HORSES USING LC-MS-MS 156
The role of clomipramine in potentiating the teratogenic effects of caffeine in pregnant rats: a histopathological study 156
PHARMACOKINETIC PROFILES OF THE ANALGESIC DRUG FLUPIRTINE IN CATS 156
Clinical studies of metronomic chemotherapy in dogs 156
Totale 25.086
Categoria #
all - tutte 157.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.397 149 304 155 303 720 604 134 251 215 160 268 1.134
2022/20233.898 548 364 298 385 513 565 88 295 564 34 188 56
2023/20246.088 622 547 526 402 668 782 218 328 136 1.089 309 461
2024/202511.967 135 546 186 644 871 972 1.012 900 1.434 1.832 1.361 2.074
2025/202613.359 678 1.580 1.488 1.228 1.028 1.321 1.797 781 959 1.335 640 524
2026/202783 83 0 0 0 0 0 0 0 0 0 0 0
Totale 59.309